Search This Blog

Loading...

Wednesday, October 19, 2011

The Cane

by Mark Dunning

“The only thing we have to fear is fear itself.” – Franklin Delano Roosevelt

It’s hard to believe that I am afraid of a white folding piece of aluminum, especially when there’s a little rubber ball on the end of it or maybe a tennis ball. Yet the cane scares me and it should scare you, but not for the reasons you think.

I was walking with a friend of mine one warm summer day along the crowded streets of Boston. She held my elbow as we were bumped and jostled by the business people racing to lunch and back. After a minute of excuse me’s and dirty looks, she stopped and unfolded her cane.

“I don’t really need it right now,” she said, “but it clears the streets.”

So it did. The stream of people parted and we walked hassle free. The cane, it turns out, has an unmatched power to divide.

And that’s the problem.

Walk with me for a moment and I’ll explain. See, we want treatments for Usher syndrome. To develop treatments we need lots of researchers doing lots of work. That costs lots of money. The best large funding source out there is the National Institute of Health. The NIH is a governmental agency that, while it is independent of Congress, certainly heads the wishes of the Congress. If enough members of Congress tell NIH to fund a certain project, NIH will fund that project. So for us to get substantial funding for Usher syndrome research from NIH to pay for lots of researchers to do lots of research, we need members of Congress to tell NIH to fund Usher syndrome research.

Members of Congress work for you. You elect them and they act on your behalf. The reason they have not asked NIH for more funding for Usher syndrome research is because we have not done a good enough job of letting them know that we want them to do that. We need everyone with Usher syndrome to work together to encourage Congress to push NIH for Usher syndrome research funding.

Recognizing that fact, we have been working to build an Usher syndrome community. We want to identify everyone with Usher syndrome, educate them on what it will take to find treatments, then enlist their help lobbying Congress for increased NIH funding (among other things). As part of that effort we have developed a Family Network to connect families and have been running annual Family Conferences to further build that Usher syndrome community we so desperately need.

Enter the cane.

Parents of young children fear the cane. Adults who’s vision is still good fear the cane. It’s not the painted aluminum they fear, obviously, but what it represents. To them it is a frightening future of limitations and loneliness. They don’t want to see anyone using a cane because they might glimpse the difficulties ahead. They don’t want to meet anyone using a cane because they might learn how this person was once happy and free and then, when the cane arrived, they turned miserable and downtrodden. The cane, to families not using the cane, is the very symbol of the fear they try so hard to control so they avoid it. They don’t want to know the truth about it because the truth might be even worse than they fear.

People who use a cane know that. They feared the cane themselves. They fought against it and dreaded the time when they would need it. They know that people look at them with their cane and make assumptions about them. They also know that the cane rather than closing doors, often opens them. The cane is a source of mobility and comfort. The cane parts crowds and allays fears. Oh sure, everyone using a cane would rather not have to use one, but given the alternative, it’s a big help. But they understand why people might fear the cane. So they avoid people who don’t use the cane because they either don’t want to upset them or they don’t want to try to explain its benefits to someone near panic.

As I said, the cane has an unmatched power to divide.

We see this all the time with the family network. Families of young children don’t want to be contacted by adults with Usher, adults who might use a cane. Adults who don’t use the cane don’t want to be contacted by adults who do. Adults who do use the cane don’t want to get involved, don’t want to invite tough questions, and don’t want to be treated with gentle fear just because they carry a piece of folding aluminum. Now none of these folks openly say that they don’t want to be contacted. They just don’t join the network or they do join but don’t contact people on the other side of that thin white line.

We see this all the time at family conferences, too. In the morning you’ll find groups of people who use a cane and groups of people who don’t.

“I shouldn’t be here,” a friend who uses a cane said to me at the last family conference, “I’m scaring people.”

“I shouldn’t be here,” a friend who has Usher but does not use a cane said to me at the last family conference, “I keep staring at the people with canes and I think I’m embarrassing them. I can't help wondering if that will be me.”

Of course, you know where this story goes. My two friends eventually met each other. Cane and No Cane. No Cane had just recently had to give up driving. Cane understood. He remembered how hard it was for him at first. No Cane met Cane’s wife, learned he had two happy, successful grown children. She felt better about her future. Cane offered advice to No Cane. He felt better about attending. For once, having Usher was a good thing. He wasn’t scaring people. He was helping people. Cane and No Cane frequently trade e-mails and advice now. They are part of the same community. That’s exactly what we need.

Look, I understand the emotions involved. I fear the cane, too. I don’t want my daughter to ever have to rely on one. I want to find treatments that make the cane unnecessary. But more than that, I fear the cane’s power to divide. Usher syndrome research is woefully underfunded because we are not a strong community and therefore not a strong lobby. And it’s our fears that are the biggest obstacle to changing that.

Thursday, October 6, 2011

Usher syndrome, part III: The Plot Thickens

by Jennifer Phillips, Ph.D.

The time has come to delve into the retinal component of Usher syndrome. In Part II, I briefly described the results of protein localization studies, in which most members of the Usher cohort were found at the connecting cilium of the photoreceptor and at the photoreceptor synapse. The following diagram summarizes these findings:

Adapted from Reiners et al, 2006. Colored blocks show subcellular localiazation of the various Usher proteins in photoreceptor cells. Colocalization is densest in the region of the connecting cilium (CC) and the synapse (S). Other abbreviations: BM: basement membrane; RPE: retinal pigmented epithelium; OS: outer segment; IS: inner segment; N: nucleus.
So, as we saw in the ear, the proteins with the equipment for physically interacting with one another are gathering in specific places, and thus multi-protein complexes are most likely to be formed at these locations. The cluster of Usher proteins around the connecting cilium has been the focus of most of the current retinal studies, and to understand the potential importance of an Usher complex at that subcellular location we must address the importance of the connecting cilium itself.

Recall the structure of the photoreceptor cell described in Part I. The inner segment, just above the nucleus, contains all the standard-issue cell operating equipment: specialized molecules required for producing protein, degrading cellular waste products and performing various other metabolic functions. The outer segment contains the intricately folded membrane discs with which light sensitive molecules are associated. Between these two cellular compartments lies the connecting cilium, which grows out of the inner segment, extends up into the outer segment, and is surrounded by a structure known as the periciliary ridge, which encircles the connecting cilium like a little cuff. The cilium serves as a functional connection between the inner and outer segments, as well as a structural one. Proteins and other cellular materials synthesized in the inner segment need to get to the outer segment in order to perform their particular jobs up there, and materials that are no longer needed in the outer segment need to be carried away and dealt with in the inner segment. The connecting cilium acts as a transport system to which motor proteins can anchor and pull their molecular cargo up or down as needed.

The localization studies of the Usher proteins reveal that many of them are in the vicinity of the connecting cilium, but a closer look at this region of the cell shows that they are specifically either in the periciliary ridge (the ‘cuff’) or the space between the periciliary ridge and the connecting cilium:


Adapted from Märker et al, 2008. Panel B shows a cutaway side view of the connecting cilium (CC) and surrounding terrain. The ‘peninsula’ (marked with a * near the top) shape to the right of the CC and beneath the outer segment (OS) is the structure known as the periciliary ridge. Panel C shows a top-down view of this same region, in which the periciliary ridge is depicted as a crescent shape that wraps around most of the circumference of the CC. In both panels, colored shapes depict the various usher proteins that are hypothesized to provide structural and functional links between the CC and the periciliary ridge. Other Abbreviations: MT: microtubules.
Thus, the model for Usher protein function in the retina is that these complexes somehow assist in the cilium-based transport system. Here’s where things get a bit sticky, though. As most of our readership knows all too well, unlike the congenital nature of the hearing defects in most forms of Usher, the retinal symptoms don’t manifest all at once. Rather than being diagnosed at birth, vision loss usually isn’t noticed until a few years later—sometimes not until adolescence. Furthermore, they progress quite slowly, well into the third decade of life in most cases. How can the same defective proteins that cause such significant developmental problems in the hair cells not cause early problems in the retina as well?

The congenital deafness in human patients and mouse models of the disease, and the defects in stereocilia formation seen in the Usher mice are nicely explained by the model of protein interaction and function in the developing hair cells, discussed in Part II. The retinal cells, however, appear to develop normally and apparently function normally until they begin to degenerate. I say ‘apparently’ because the ‘pre-death’ state of the photoreceptors has been difficult to observe thus far. Historically, the first sign of a problem in human Usher patients occurs when the hearing-impaired child or teenager begins to experience night blindness due to a loss of rod photoreceptors in the periphery of the eye. By the time of this first clinical exam in such cases, the degeneration is already well underway. Fortunately (from an investigative point of view, at least) this is changing with genetic screening and early identification of Usher patients, but even with earlier eye exams it’s still not at all clear what is going wrong in the retina at the molecular level.

At this point you might well ask what clues the Usher mutant mice, which proved so valuable in adding to our understanding of the disease progression in the ear, can tell us about the events leading up to retinal degeneration. To our great consternation, most of the originally identified Usher mice do not undergo retinal degeneration at all! A number of these mutant mice have been examined expectantly until the end of their natural lives (around 2 years) and most do not exhibit any abnormality in their retinas. The exceptions to this are older mice with mutations in the Cadherin 23 (ush1d) gene, which show a slight reduction in visual function older ages, and Myo7a (ush1b) mutant mice, which exhibit a fairly distinct defect in moving proteins around in the retinal pigmented epithelium. Neither type of mouse shows any retinal degeneration.

Several theories have been put forth to explain this discrepancy between the mouse and human forms of the retinal disease. One possibility is that mice, being nocturnal animals and usually raised in low-light laboratory conditions, may not endure the bright light exposure that human retinas must withstand. Another explanation may lie in the slow, progressive nature of the human disease and the relatively short life cycle of the mouse—perhaps two years just isn’t long enough for the retinal defects to manifest in the mouse retina. A third theory centers on the fact that all of the known Usher proteins actually exist in multiple variations—the genetic code that specifies each of these proteins can be cut and spliced in a few different ways, giving rise to similar, but not identical protein products. The exact roles of the different isoforms of every gene aren’t yet clear, but some of them do appear to be more important in the ear than in the eye. It’s possible that the mutations in mouse Usher genes that give rise to such a strong ear phenotypes don’t affect the part of the protein that’s important for retinal cell function, and thus the mouse is spared the vision loss that characterizes the human disease. In further support of this latter theory is that fact that many of the Usher syndrome genes are also linked to non-syndromic deafness in humans—hearing loss without associated blindness.

None of the above theories are mutually exclusive, and it may turn out to be a combination of genetics, environment and life span that has limited the retinal phenotype of these Usher mutant mice. Encouragingly, excellent progress has been made through the use of genetically engineered mice, in which an Usher protein is removed completely (see knockout mice for more on this technique) or, alternatively, a targeted mutation is introduced into a particular Usher gene that renders the encoded protein non-functional. Thus far, these genetically modified mice show late-onset retinal degeneration (I’ve blogged about two such strains previously, here and here) and are providing important new avenues for therapeutic research. In these mice, therefore, we have a more complete model of Usher syndrome, although the retinal degeneration still appears to initiate later in mouse development than in the corresponding human lifespan. Moreover, as useful as these new strains have been, the Knockout technique isn’t foolproof. Knockout mice for at least two Usher genes (Ush1c and Clrn1) have not displayed significant retinal degeneration in any studies published to date.

In short, there are still a great many unanswered questions surrounding the pathophysiology of Usher syndrome, particularly with respect to the retinal phenotype. To complement the data being collected from the mouse models, myself and other scientists have investigated various Usher proteins in the zebrafish. There are some differences in the retinal anatomy of zebrafish and humans, but basic cell structure and function is conserved between the two species. Additionally, there are some similarities that make zebrafish an especially appealing organism for this type of study, including the fact that fish are diurnal animals with rich color vision--even better than humans, in fact, as they can see light in the ultraviolet range of the spectrum. Other advantages to using zebrafish are related to their development. Zebrafish embryos undergo fertilization and development outside the mother’s body, and usually several hundred embryos are produced from a single mating. They develop rapidly and are able to swim, see and hear just a few days after fertilization. Thus, we can conduct vision, hearing and balance tests within the first week of development and obtain results quite rapidly to learn more about the consequences of losing Usher gene function.

Understanding the cellular events that precede the death of these cells will be crucial in identifying ways to improve diagnosis and treatment of Usher syndrome. In the conclusion of the Usher story, I’ll discuss current clinical practices for managing Usher syndrome, and the direction of the research efforts designed to enhance these treatments.